Impact Biomedical IBO
NYSE IBO
$5.30 -0.13 (-2.39%)
As of: Oct 2, 2026 · 11:07 AM EDT

Impact Biomedical (IBO) Price to Book (2024 - 2026)

Updated

Impact Biomedical's (IBO) Price to Book stood at 3.54 in Q2 2026, down 19.5% from the prior quarter.

Analysis

Impact Biomedical (IBO) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Impact Biomedical's Price to Book came in at 1.01, down 56.0% from FY2024.

  • Across earlier years, Price to Book came in at 2.30 in FY2024.
  • Quarterly Price to Book has ranged from 0.67 in Q3 2024 to 4.40 in Q1 2026 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.54
Mar 31, 2026 4.40
Dec 31, 2025 1.01
Mar 31, 2025 1.54
Dec 31, 2024 2.30
Sep 30, 2024 0.67
API Access

Impact Biomedical Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=IBO&period=max&api_key=YOUR_API_KEY